Evidence map›Paper›PMID 33217055›Full record

Observational studyJournal of gastroenterology and hepatology2021

Impact of COVID-19 pandemic on fecal immunochemical test screening uptake and compliance to diagnostic colonoscopy.

Shao-Yi Cheng, Chu-Fen Chen, Hsien-Chin He, Li-Chun Chang, Wen-Feng Hsu, Ming-Shiang Wu, Han-Mo Chiu

Open access · bronzeAbstract readObservational Study
PubMed Full text at PMC Publisher
In one paragraph

Observational study in Journal of gastroenterology and hepatology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 2 pooled it
2.3field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 2 syntheses or guidelines pooled it, 40 citations in OpenAlex.

  1. Pooled it
  2. Guideline
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Shao-Yi ChengDepartment of Family Medicine, College of Medicine and Hospital, National Taiwan University, Taipei, Taiwan.ORCID https://orcid.org/0000-0002-2224-4140
Chu-Fen ChenCancer Administration and Coordination Center, National Taiwan University Hospital, Taipei, Taiwan.
Hsien-Chin HeCancer Administration and Coordination Center, National Taiwan University Hospital, Taipei, Taiwan.
Li-Chun ChangDepartment of Internal Medicine, College of Medicine and Hospital, National Taiwan University, Taipei, Taiwan.
Wen-Feng HsuDepartment of Internal Medicine, National Taiwan University Cancer Center, Taipei, Taiwan.ORCID https://orcid.org/0000-0001-7138-2614
Ming-Shiang WuDepartment of Internal Medicine, College of Medicine and Hospital, National Taiwan University, Taipei, Taiwan.
Han-Mo ChiuDepartment of Internal Medicine, College of Medicine and Hospital, National Taiwan University, Taipei, Taiwan.ORCID https://orcid.org/0000-0003-2786-8056
National Taiwan University Hospital · TWNational Taiwan University · TW

Funding

Cancer Administration and Coordination Center, National Taiwan University HospitalHealth Promotion Administration, Ministry of Health and Welfare (A1081113), Taiwan.
6 · The paper itself

Abstract

BACKGROUND AND

aimDuring this COVID-19 pandemic, Taiwan is one of the few countries where fecal immunochemical test and endoscopic activity for colorectal cancer screening keeps ongoing. We aimed to investigate how screening uptake and colonoscopy rate were affected in one of the biggest screening hubs in Northern Taiwan.

methodsWe conducted a prospective observational study tracing and analyzing the screening uptake and the trend of compliance to diagnostic colonoscopy in fecal immunochemical test-positive subjects in the National Taiwan University Hospital screening hub since the outbreak of COVID-19 and compared it with that of the corresponding periods in the past 3 years. Cancellation and rescheduling rates of colonoscopy and related reasons were also explored.

resultsScreening uptake during December 2019 to April 2020 was 88.8%, which was significantly lower than that in the corresponding period of the past 3 years (91.2-92.7%, P for trend < 0.0001). Colonoscopy rate in this period was 66.1%, which was also significantly lower than that in the past 3 years (70.2-77.5%, P for trend = 0.017). Rescheduling or cancellation rate was up to 10.9%, which was significantly higher than that in the past 3 years (P for trend = 0.023), and half of them was due to the fear of being infected.

conclusionFecal immunochemical test screening was significantly affected by COVID-19 pandemic. In order to resume the practice in COVID-19 era, screening organizers should consider various approaches to secure timely diagnosis of colorectal cancer.

Indexed as

Colorectal NeoplasmsCOVID-19Early Detection of CancerHealth Services MisuseOccult BloodAgedColonoscopyCommunicable Disease ControlHealth Services Needs and DemandHumansMaleMiddle AgedPatient Acceptance of Health CareProspective StudiesSARS-CoV-2TaiwanColonoscopyColorectal cancerCOVID-19Screening

Identifiers

PMID33217055
PMCPMC7753615
OpenAlexW3098786198

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.